Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.

Medical device company Boston Scientific (NYSE:BSX) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 22.4% year on year to $4.56 billion. Guidance for next ...

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

The rise of inspiring deep tech entrepreneurs and the ecosystems around them is one of the most fascinating business ...

PRNewswire Bangalore Karnataka [India] 3 New York-based VJ Group announced the launch of its newest venture VJ Bio a biotech ...

It took more than 50 years for Marthe Gautier to set the record straight about her discovery of the genetic cause of Down ...

Evolution of Ferment conference to kick off Summer 2025. BOSTON, Feb. 6, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), ...

9th Military Vision Symposium on Novel Technology and Vision Restoration hosted by Harvard Medical School Department of Ophthalmology and Mass Eye and Ear, February 27-28, 2025, at the Starr Center ...

Quantum computing might be Wall Street's next big hype cycle. Rigetti offers excellent exposure to the infrastructure side of the opportunity. But is it too early to get involved? Investors will want ...